Xianzhong Meng Selected Research

Spinal Cord Ischemia

1/2022	Optimizing Nicorandil for Spinal Cord Protection in a Murine Model of Complex Aortic Intervention.
1/2019	Pretreatment With Diazoxide Attenuates Spinal Cord Ischemia-Reperfusion Injury Through Signaling Transducer and Activator of Transcription 3 Pathway.
12/2018	Synergistic Reduction of Apoptosis With Diazoxide and Erythropoietin in Spinal Cord Ischemic Injury.
1/2018	Optimized induction of beta common receptor enhances the neuroprotective function of erythropoietin in spinal cord ischemic injury.
7/2015	Spinal Cord Ischemia-Reperfusion Injury Induces Erythropoietin Receptor Expression.
3/2015	Erythropoietin activates the phosporylated cAMP [adenosine 3'5' cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury.
9/2013	Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury.
11/2012	Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine.
9/2012	The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury.
1/2011	Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianzhong Meng Research Topics

Disease

20	Inflammation (Inflammations) 01/2022 - 08/2006
18	Ischemia 01/2022 - 02/2002
13	Neoplasms (Cancer) 01/2022 - 03/2010
12	Reperfusion Injury 01/2019 - 06/2008
10	Adenocarcinoma 10/2022 - 03/2010
10	Spinal Cord Ischemia 01/2022 - 01/2011
8	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2008
7	Lung Neoplasms (Lung Cancer) 10/2020 - 02/2012
7	Myocardial Ischemia (Ischemic Heart Diseases) 03/2016 - 02/2002
7	Endotoxemia 09/2014 - 01/2002
6	Hyperplasia 10/2022 - 08/2002
6	Aortic Valve Disease 12/2021 - 11/2012
6	Hemorrhagic Shock 11/2015 - 05/2002
4	Infarction (Infarctions) 01/2022 - 12/2011
4	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 12/2009
4	Adenocarcinoma of Lung 10/2020 - 02/2012
4	Atherosclerosis 01/2019 - 12/2010
4	Paraplegia (Spastic Paraplegia) 03/2015 - 01/2011
4	Acute Lung Injury 06/2012 - 04/2003
3	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 01/2011
3	Stroke (Strokes) 11/2020 - 05/2013
3	Intervertebral Disc Displacement (Herniated Disc) 12/2019 - 04/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 09/2012
3	Gastroesophageal Reflux (GERD) 03/2010 - 06/2008
3	Sepsis (Septicemia) 09/2004 - 05/2002
2	Carcinogenesis 01/2022 - 06/2008
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 05/2011
2	Neurologic Manifestations (Neurological Manifestations) 12/2019 - 01/2011
2	Myocardial Infarction 01/2019 - 12/2011
2	Metaplasia 01/2019 - 06/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018 - 03/2015
2	Sclerosis 06/2017 - 01/2017
2	Transfusion-Related Acute Lung Injury 01/2017 - 02/2009
2	Infections 12/2015 - 03/2010
2	Shock 11/2015 - 06/2012
2	Vascular Calcification 11/2015 - 04/2011
2	Neoplasm Metastasis (Metastasis) 09/2012 - 02/2012
1	Esophageal Diseases 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022

Drug/Important Bio-Agent (IBA)

13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011 - 02/2002
11	Secretory Phospholipases A2IBA 01/2021 - 12/2009
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2008
8	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2008
8	Toll-Like Receptor 4IBA 01/2022 - 03/2005
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022 - 08/2002
7	Phospholipases (Phospholipase)IBA 04/2013 - 06/2008
6	EnzymesIBA 11/2020 - 06/2008
5	Simvastatin (Zocor)FDA LinkGeneric 10/2022 - 11/2011
5	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2011
5	NF-kappa B (NF-kB)IBA 01/2021 - 02/2002
5	Erythropoietin FDA Link 12/2018 - 01/2011
5	CytokinesIBA 01/2017 - 08/2006
4	InterleukinsIBA 01/2020 - 08/2006
4	oxidized low density lipoproteinIBA 01/2017 - 04/2011
4	Messenger RNA (mRNA)IBA 07/2015 - 02/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 11/2011
3	Nicorandil (SG 75)IBA 01/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2016
3	Diazoxide (Hyperstat)FDA Link 10/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2021 - 03/2015
3	Oxygen (Dioxygen)IBA 05/2015 - 08/2007
3	BiglycanIBA 04/2015 - 11/2012
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022 - 08/2002
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2012
2	CollagenIBA 01/2022 - 06/2017
2	CalciumIBA 12/2021 - 07/2008
2	Potassium Channels (Potassium Channel)IBA 10/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 10/2021 - 01/2021
2	SolutionsIBA 01/2021 - 01/2021
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 11/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2020 - 03/2015
2	Nerve Growth Factors (Neurotrophins)IBA 11/2020 - 03/2015
2	Matrilin ProteinsIBA 01/2020 - 01/2017
2	Neuroprotective AgentsIBA 12/2018 - 01/2018
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015 - 09/2014
2	EicosanoidsIBA 08/2014 - 06/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2014 - 05/2002
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2012 - 06/2008
2	Group II Phospholipases A2IBA 11/2012 - 09/2012
2	Hematoxylin (Haematoxylon)IBA 11/2012 - 06/2008
2	AcidsIBA 05/2011 - 04/2010
2	Interleukin-1beta (Interleukin 1 beta)IBA 02/2011 - 08/2002
2	Hemoglobins (Hemoglobin)IBA 04/2009 - 08/2007
2	Peptides (Polypeptides)IBA 05/2008 - 02/2002
2	NF-KappaB Inhibitor alphaIBA 02/2003 - 02/2002
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	KATP ChannelsIBA 01/2022
1	Choline (Choline Chloride)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 10/2021
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 10/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021

Therapy/Procedure

7	Therapeutics 10/2018 - 01/2011
3	Injections 01/2021 - 12/2011
2	Operative Surgical Procedures 02/2018 - 08/2016
2	Diskectomy (Discectomy) 02/2018 - 04/2008
1	Heart Transplantation (Grafting, Heart) 01/2022